This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Seoul National University, Lemonex Inc.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2025-2026
Title: Dal Hee Min: Innovator in Pharmaceutical Composition for Flavivirus Treatment
Introduction
Dal Hee Min is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of flavivirus infections. His innovative approach has the potential to impact public health positively.
Latest Patents
Dal Hee Min holds a patent for a pharmaceutical composition aimed at preventing or treating flavivirus infections. This method involves administering a composition that includes various compounds such as gentamicin sulfate, netilmicin, tobramycin, and hydroxychloroquine, among others. These compounds have demonstrated excellent growth inhibition or killing effects on various species of the flavivirus genus.
Career Highlights
Throughout his career, Dal Hee Min has worked with reputable organizations, including Lemonex Inc. and Seoul National University. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Dal Hee Min has collaborated with notable colleagues, including Cheol Hee Won and Jae Ho Lee. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical field.
Conclusion
Dal Hee Min's contributions to the development of pharmaceutical compositions for flavivirus treatment highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile